CMS names vendor for certain Part B drugs
CMS has selected Bioscrip as the first national vendor for the newCompetitive Acquisition Program (CAP) for certain Medicare Part Bdrugs and biologicals beginning July 1. Participating physicianswill acquire the drugs from Bioscrip and administer them tobeneficiaries instead of purchasing them from distributors andbeing reimbursed by Medicare.
CMS has selected Bioscrip as the first national vendor for the new Competitive Acquisition Program (CAP) for certain Medicare Part B drugs and biologicals beginning July 1. Participating physicians will acquire the drugs from Bioscrip and administer them to beneficiaries instead of purchasing them from distributors and being reimbursed by Medicare. Under the CAP program, the vendor is responsible for billing Medicare, collecting any coinsurance, and other administrative duties. Physicians will still be paid for administering the drugs. More CAP vendors will be named later. The Web site is at http://www.cms.hhs.gov/CompetitiveAcquisforBios/.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
To go to the Drug Topics homepage, click here http://www.drugtopics.com.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
